Showing 1 - 10 of 18
Persistent link: https://www.econbiz.de/10009735806
Persistent link: https://www.econbiz.de/10003803535
"We compute quality-adjusted price indexes for Personal Digital Assistants (PDAs) for the period 1999-2004, using data on prices and characteristics of 203 models sold by 12 manufacturers. The PDA market is growing in size, it is technologically dynamic with very substantial changes in measured...
Persistent link: https://www.econbiz.de/10002221410
We compute quality-adjusted price indexes for Personal Digital Assistants (PDAs) for the period 1999-2004, using data on prices and characteristics of 203 models sold by 12 manufacturers. The PDA market is growing in size, it is technologically dynamic with very substantial changes in measured...
Persistent link: https://www.econbiz.de/10012467944
We compute quality-adjusted price indexes for Personal Digital Assistants (PDAs) for the period 1999-2004, using data on prices and characteristics of 203 models sold by 12 manufacturers. The PDA market is growing in size, it is technologically dynamic with very substantial changes in measured...
Persistent link: https://www.econbiz.de/10013228269
The celebrated economist Zvi Griliches’s entire career can be viewed as an attempt to advance the cause of accuracy in economic measurement. His interest in the causes and consequences of technical progress led to his pathbreaking work on price hedonics, now the principal analytical technique...
Persistent link: https://www.econbiz.de/10014487971
Persistent link: https://www.econbiz.de/10001619491
Persistent link: https://www.econbiz.de/10000990323
We examine the relationship between quality'' and market outcomes for a group of drugs used to treat rheumatoid arthritis. Though this is a widespread and debilitating disease with very substantial impacts on the health of patients and on the economy, currently available drugs have limited...
Persistent link: https://www.econbiz.de/10013222962
We examine the relationship between quality'' and market outcomes for a group of drugs used to treat rheumatoid arthritis. Though this is a widespread and debilitating disease with very substantial impacts on the health of patients and on the economy, currently available drugs have limited...
Persistent link: https://www.econbiz.de/10012472235